According to a statement from the national institute of health (NIH), it has obtained "formal approval" from the drug regulatory authority of Pakistan (DRAP) for phase-III Clinical Trial of Recombinant Novel Coronavirus Vaccine Adenovirus Type 5 vector (Ad5-nCoV) developed by CanSinoBio and Beijing Institute of Biotechnology China (BIB)".
Luggage
Carts 
Luggage
Locks
Luggage
Scales
Luggage
Straps
Luggage Tags
Handle
Wraps
Packing
Organizers
Passport
Wallets
Shoe Bags
Toiletry
Bags
Travel Bottles & Containers 
Earplugs
Keyrings & Keychains 
Luggage
Accessories
Money
Clips
Sleep
Masks
Travel
Blankets
Travel Kits & Organizers
Travel
Lights
Umbrellas
Luggage
Locks
Luggage
Scales
Luggage
Straps
Luggage Tags
Handle
Wraps
Packing
Organizers
Passport
Wallets
Shoe Bags
Toiletry
Bags
Travel Bottles & Containers 
Earplugs
Keyrings & Keychains 
Luggage
Accessories
Money
Clips
Sleep
Masks
Travel
Blankets
Travel Kits & Organizers
Travel
Lights
Umbrellas
Tuesday, August 18, 2020
Pakistan to conduct phase-III clinical trial of Covid-19 vaccine August 18, 2020 at 01:52AM
According to a statement from the national institute of health (NIH), it has obtained "formal approval" from the drug regulatory authority of Pakistan (DRAP) for phase-III Clinical Trial of Recombinant Novel Coronavirus Vaccine Adenovirus Type 5 vector (Ad5-nCoV) developed by CanSinoBio and Beijing Institute of Biotechnology China (BIB)".
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment